Apple Print, Index Drama, and Bears in the Chip Aisle

Apple Anchors a Heavy Earnings Week

The biggest print of the week is AAPL on Sunday night. The $5 trillion company reports Q4 results after the bell on November 2. AMGN and CRBG follow Monday morning. ALL and COR report Tuesday. The sequence gives investors their clearest read yet on consumer spending, biotech pipelines, and insurance loss trends. ERIE opens the US earnings calendar this morning with a pre-market print.

Chips Under Pressure, Financials Catching Bids

Bearish options flow dominated semiconductors this week. MU topped ORTEX's negative-bets rankings despite a 244% year-to-date gain. META RSI has fallen to 30.7, firmly oversold territory, after a week of heavy put activity. On the other side, financial names drew bullish options flow. ICE was among the standouts on the positive side of the ledger.

Analyst pressure landed on industrials and tech. Wells Fargo cut its target on LII to $355 from $424. FTNT absorbed a trim to $140 from Piper Sandler.

Russell Cut-Off Day

Today is the closing-price rank date for the Russell 2000 December review. Ninety-seven names remain in play. Health Catalyst sits exactly on the $135M entry line. UWMC needs just +0.4% to cross into the Russell 2000 from the Russell 1000 side. Viasat's deletion odds jumped overnight from 47% to 80%. Twist Bioscience moved the same way. A deletion for either would trigger over $1.3B in forced selling each.

Europe: Recordati Deal Nears Close

In European deal news, CVC Capital Partners' agreed cash-and-stock offer for Italian pharma group Recordati carries an 88% completion probability. An FTSE MIB deletion announcement is expected November 6, which would force $218M of selling across 11 days of normal volume. RACE also reports next week, where Austrian car registration data is running 75% below the same quarter last year, a signal to watch given the stock's near-term print.